+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Advances in Clinical Chemistry. Volume 102

  • Book

  • May 2021
  • Elsevier Science and Technology
  • ID: 5238344

Advances in Clinical Chemistry, Volume 102, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the most up-to-date technologies related to the field of clinical chemistry. Chapters in this new release cover Advances in immunosensor technology, Extracellular Vesicles: Roles and Applications in Drug-Induced Liver Injury, Oxidative stress biomarkers in the preterm infant, Translational biomarkers in the era of precision medicine, Metabolomics applications in coronary artery disease personalized medicine, Quantitative EEG biomarkers for epilepsy and their relation to chemical biomarkers.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Advances in immunosensor technology Muhammet Aydin, Elif Burcu Aydin and Mustafa Kemal Sezgint?rk 2. Extracellular Vesicles: Roles and Applications in Drug-Induced Liver Injury David S. Umbaugh and Hartmut Jaeschke 3. Oxidative stress biomarkers in the preterm infant Angel Sanchez-Illana, Jose David Pineiro-Ramos, Victoria Ramos-Garcia, Isabel Ten-Domenech, Maximo Vento and Julia Kuligowski 4. Translational biomarkers in the era of precision medicine Laura Bravo-Merodio, Animesh Acharjee, Dominic Russ, Vartika Bisht, John A. Williams, Loukia G. Tsaprouni and Georgios V. Gkoutos 5. Metabolomics applications in coronary artery disease personalized medicine Arwa M. Amin 6. Quantitative EEG biomarkers for epilepsy and their relation to chemical biomarkers Yvonne Holler and Raffaele Nardone

Authors

Gregory S. Makowski Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USA. Dr Gregory S Makowski is a board certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in his joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President and Chief Scientific Officer for Clinical Laboratory Partners in Newington CT, USA.